At a glance
- Originator Bristol-Myers Squibb
- Class Cardiovascular therapies
- Mechanism of Action Sodium hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 24 Apr 2002 Preclinical trials in Angina pectoris in USA (unspecified route)